Asprole 150 Tablet contains Aspirin 150mg, a clinically trusted antiplatelet medicine widely used for cardiovascular protection and thrombotic event prevention. It inhibits platelet aggregation, reducing the risk of heart attack, stroke, and other cardiovascular complications.
Aspirin’s proven efficacy in low-dose therapy makes it ideal for long-term use in patients with coronary artery disease, ischemic heart conditions, or high-risk cardiovascular profiles. Its predictable pharmacokinetics and safety profile ensure reliable prevention of blood clot formation.
For distributors and resellers, Aspofoli 150 Tablet is a high-demand cardiovascular product, frequently prescribed in cardiology OPDs, hospitals, and preventive care clinics. Its consistent requirement ensures steady movement and repeated orders throughout the year.
Adding Asprole 150 Tablet to your cardiology and cardiovascular segment strengthens your product portfolio, opening opportunities for hospital supply, pharmacy distribution, institutional tenders, export markets, and third-party manufacturing. Its essential role in heart health management makes it a profitable and strategic addition for pharmaceutical distributors.